Treatment escape reduces the effectiveness of cabergoline during long ‐term treatment of acromegaly in monotherapy or in association with first‐generation somatostatin receptor ligands

Clinical Endocrinology, EarlyView.

Source: Clinical Endocrinology - April 6, 2018 Category: Endocrinology Authors: Leandro Kasuki , Marilia Duarte Dalmolin , Luiz Eduardo Wildemberg , M ônica R. Gadelha Source Type: research